Antigen-driven regulation of experimental autoimmune encephalomyelitis

Research in Immunology

Volumn 149, Issue 9, 1998, Pages

  Kuchroo, V K ^a   Weiner, H L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLOPHOSPHAMIDE; CYTOKINE; GLYCOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; CENTRAL NERVOUS SYSTEM; DISEASE PREDISPOSITION; IMMUNOMODULATION; LYMPHOID ORGAN; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STRAIN DIFFERENCE;

EID: 0032209152     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(99)80003-0     Document Type: Article

References (141)

1. Aharoni, R., Teitelbaum, D., Sela, M. & Arnon, R. (1997), Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc. Nat. Acad. Sci., USA, 94, 10821-10826.
2. Balashov, K.E., Smith, D.R., Khoury, S.J., Hafler, D.A. & Weiner, H.L. (1997), Increased IL12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA., 94, 599-603.
3. Barnett, M.L., Combitchi, D. & Trentham, D.E. (1996), A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum., 39, 623-628.
4. Barnett, M.L., Kremer, J.M., St. Clair, E.W., Clegg, D.O., Furst, D., Weisman, M., Fletcher, M.J.F., Lavin, P.T., Finger, E., Morales, A., Le, C.H. & Trentham, D.E. (1998), Treatment of rheumatoid arthritis with oral type II Collagen: results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum., 41, 290-297.
5. Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G. & Janeway, J., C.A. (1993), Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med., 177, 57-68.
6. Becker, K.J., McCarron, R.M. & Hallenbeck, J.M. (1997), Oral tolerance to myelin basic protein decreases stroke size. Stroke, 28, 246.
7. Ben-Nun, A., Wekerle, H. & Cohen, I.R. (1981), The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol., 11, 195-199.
8. Bendelac, A. (1995), Mouse NK1+ T cells. Curr. Op. Immunol., 7, 367-374.
9. Bergerot, I., Fioix, C., Peterson, J., Moulin, V., Rask, C., Fabien, N., Lindblad, M., Mayer, A., Czerkinsky, C., Holmgren, J. & Thivolet, C. (1997), A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci., USA, 94, 4610-4614.
10. Bernard, C.C.A. (1976), Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J. Immunogenet., 3, 263-274.
11. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E. & Carton, H. (1988), Enhancement of experimental allergic encephalomyelitis by antibodies against IFN-γ. J. Immunol., 140, 1506-1510.
12. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D., Veromaa, T., Waisman, A., Gaur, A., Conlon, P., Ling, N., Fairchild, P., Wraith, D., O'garra, A., Fathman, C. & Steinman, L. (1996), Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature, 379, 343-346.
13. Brostoff, S.W. & Mason, D.W. (1984), Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J. Immunol., 133, 1938-1942.
14. Chase, M. (1946), Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol Med., 61, 257-259.
15. Chen, Y., Hancock, W.W., Marks, R., Gonnella, P.A. & Weiner, H.L. (1998), Mechanisms of recovery from experimental allergic encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice. J. Neuroimmunol., 82, 149-159.
16. Chen, Y., Inobe, J.-I., Marks, R., Gonnella, P., Kuchroo, V.K. & Weiner, H.L. (1995), Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature, 376, 177-180.
17. Chen, Y., Inobe, J.-I. & Weiner, H.L. (1997), Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell. Immunol., 178, 62-68.
18. Chen, Y., Kuchroo, V.K., Inobe, J.-I., Hafler, D.A. & Weiner, H.L. (1994), Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science, 265, 1237-1240.
19. Chin, Y.H., Cai, J.P. & Xu, X.M. (1992), Transforming growth factor-β1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes. J. Immunol., 148, 1106-1112.
20. Comabella, M., Balashov, K., Smith, D., Weiner, H.L. & Khoury, S.J. (1998), Cyclophosphamide treatment normalizes the increased IL-12 production in patients with chronic progressive MS and induces a Th2 cytokine switch. AAN 1998 Scientific Abstract Program, (in press).
21. Constant, S.L. & Bottomly, K. (1997), Induction of Th1 and Th2 CD4+ T cell responses : alternative approaches. Annu. Rev. Immunol., 15, 297-322.
22. Cross, A.H., Tuohy, V.K. & Raine, C.S. (1993), Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol., 146, 261-270.
23. Daynes, R., Araneo, B., Dowell, T., Huang, K. & Dudley, D. (1990), Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J. Exp. Med., 171, 979-996.
24. De Magistris, M.T., Alexander, J., Coggeshall, M., Altmann, A., Gaeta, F.C.A., Grey, H.M. & Sette, A. (1992), Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell, 66, 625-634.
25. Elson, C.O. & Ealding, W. (1984), Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol., 133, 2892-2897.
26. Elson, C.O., Tomasi, M., Dertzbaugh, M.T., Thaggard, G., Hunter, R. & Weaver, C. (1996), Oral antigen delivery by way of a multiple emulsion system enhances oral tolerance, in "Oral Tolerance : Mechanisms and Applications" (H.L. Weiner and L.F. Mayer) (pp. 156-162). Annals New York Academy of Sciences, New York.
27. Evavold, B.D. & Allen, P.M. (1991), Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science, 252, 1308-1310.
28. Ferber, I.A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. & Fathman, C.G. (1996), Mice with disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol., 156.
29. Friedman, A. & Weiner, H. (1994), Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA, 91, 6688-6692.
30. Fukaura, H., Kent, S.C., Pietrusewicz, M.J., Khoury, S.J., Weiner, H.L. & Hafler, D.A. (1996), Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest., 98, 70-77.
31. Garside, P., Steel, M., Liew, F.Y. & Mowat, A.M. (1995a), CD4+ but not CD8+ T cells are required for the induction of oral tolerance. Int. Immunol., 7, 501-504.
32. Garside, P., Steel, M., Worthey, E.A., Satoskar, A., Alexander, J., Bluethmann, H., Liew, F.Y. & Mowat, A.M. (1995b), T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol., 154, 5649-5655.
33. Gautam, S.C., Chikkala, N.F. & Battisto, J.R. (1990), Oral administration of the contact sensitizer trinitrochloro-benzene: initial sensitization and subsequent appearance of a suppressor population. Cell. Immunol., 125, 437-448.
34. Gonnella, P.A., Chen, Y., Inobe, J.-I., Quartulli, M. & Weiner, H.L. (1998), In situ immune response in gut associated lymphoid tissue (GALT) following oral antigen in TcR transgenic mice. J. Immunol., in press.
35. Gregerson, D.S., Obritsch, W.F. & Donoso, L.A. (1993), Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J. Immunol., 151, 5751-5761.
36. Harrison, L.C. (1992), Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol. Today, 13, 348-352.
37. Heinzel, F.P., Sadick, B.J., Holady, R.L., Coffman, R.L. & Locksley, R.M. (1989), Reciprocal expression of interferon gamma or interleukin 4 during the resolution of progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med., 169, 59-72.
38. Hohol, M.J., Khoury, S.J., Cook, S.L., Orav, J., Hafler, D.A. & Weiner, H.L. (1996), Three-year open protocol continuation study of oral tolenzation with myelin antigens in multiple sclerosis and design of a phase III pivotal trial, in "Oral Tolerance: Mechanisms and Applications" (H.L. Weiner and L.F. Mayer) (pp. 243-250). Annu. New York Acad. Sci., New York.
39. Hörnquist, E. & Lycke, N. (1993), Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol., 23, 2136-2143.
40. Inobe, J.-I., Chen, Y., Liu, L. & Weiner, H.L. (1998), IL-4 is a differentiation factor for TGF-β secreting T cells and has a synergistic effect in oral tolerance. Eur. J. Immunol. (in press).
41. Janeway, C.A. (1989), Immunotherapy by peptides ? Nature, 341, 482.
42. Karpus, W., Gould, K. & Swanborg, R. (1992), CD4+ suppressor T cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin 4 secretion. Eur. J. Immunol., 22, 1757.
43. Karpus, W. & Swanborg, R. (1991), CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor beta. J. Immunol., 146, 1163-1168.
44. Karpus, W.J. & Lukacs, N.W. (1996), The role of chemokines in oral tolerance: abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1, in "Oral Tolerance : Mechanisms and Applications" (H.L. Weiner and L.F. Mayer) (pp. 133-144). Annals New York Academy of Sciences, New York.
45. Kaufman, D.I., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G.S.P., Robinson, P., Atkinson, M.A., Sercarz, E.E., Tobin, A.J. & Lehmann, P.V. (1993), Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature, 366, 69-72.
46. Ke, Y. & Kapp, J.A. (1996), Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells. J. Immunol., 156, 916-921.
47. Kennedy, M.K., Torrance, D.S., Picha, K.S. & Mohler, K.M. (1992), Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol., 149, 2496-2505.
48. Kerlero de Rosbo, N., Milo, R., Lees, M.B., Burger, D., Bernard, C.C.A. & Ben-Nun, A. (1993), Reactivity to myelin antigens in multiple sclerosis: peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein, J. Clin. Invest., 92, 2602-2608.
49. Khoury, S.J., Hancock, W.W. & Weiner, H.L. (1992), Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis as associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med., 176, 1355-1364.
50. Khoury, S.J., Lider, O., al-Sabbagh, A. & Weiner, H.L. (1990), Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell. Immunol., 131, 302-310.
51. Kim, P.-H. & Kagnoff, M.F. (1990), Transforming growth factor-β1 is a costimulator for IgA production. J. Immunol., 144, 3411-3416.
52. Kuchroo, V., Prabhu Das, M., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N. & Glimcher, L.H. (1995), B7-1 and B7-2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell, 80, 707-718.
53. Kuchroo, V.K., Martin, C.A., Greer, J.M., Ju, S.-T., Sobel, R.A. & Dorf, M.E. (1993), Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol., 151, 4371-4382.
54. Kuchroo, V.K., Sobel, R.A., Laning, J.C., Martin, C.A., Greenfield, E., Dorf, M.E. & Lees, M.B. (1992), Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage. J. Immunol., 148, 3776-82.
55. Lafaille, J.J., Keere, F.V., Hsu, A.L., Baron, J.L., Haas, W., Raine, C.S. & Tonegawa, S. (1997), Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med., 186, 307-312.
56. Lamont, A., Sette, A., Fujinami, R., Colon, S., Miles, C. & Grey, H. (1990), Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IA molecules. J. Immunol., 145, 1687.
57. Lehmann, P., Forsthuber, T., Miller, A. & Sercarz, E. (1992), Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature, 358, 155.
58. Leonard, J.P., Waldburger, K.E. & Goldman, S.J. (1995), Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med., 181, 381-386.
59. Lider, O., Santos, L.M., Lee, C.S., Higgins, P.J. & Weiner, H.L. (1989), Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J. Immunol., 142, 748-752.
60. Litzenburger, T., Fassler, R., Bauer, J., Lassmann, H., Linington, C., Wekerle, H. & Iglesias, A. (1998), B lymphocytes producing demyelinating autoantibodies : development and function in gene-targeted transgenic mice. J. Exp. Med., 188, 169-180.
61. Liu, L., Kuchroo, V.K. & Weiner, H.L. (1998), B7.2 but not B7.1 costimulation is required for the induction of low dose oral tolerance. FASEB, I, A597.
62. Lublin, F.D., Knobler, R.L., Doherty, P.C. & Komgold, R. (1986), Relapsing experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice. Clin. Exp. Immunol., 66, 491-496.
63. Marinaro, M., Boyaka, P.M., Finkelman, F.D., Kiyono, H., Jackson, R.J., Jirillo, E. & McGhee, J.R. (1997), Oral but not parental interleukin (IL)-12 redirects T helper 2 (Th2)-type reponses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med., 185, 415-427.
64. Marth, T., Strober, W. & Kelsall, B.L. (1996), High dose oral tolerance in ovalbumin TCR-transgenic mice: Systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J. Immunol., 157, 2348-2357.
65. Mathisen, P.M., Yu, M., Johnson, J.M., Drazba, J.A. & Tuohy, V.K. (1997), Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med., 186, 159-164.
66. McCarron, R., Fallis, R. & McFarlin, D. (1990), Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephlomyelitis. J. Neuroimmunol., 29, 73-79.
67. Melamed, D., Fishman-Lovell, J., Uni, Z., Weiner, H.L. & Friedman, A. (1996), Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin. Int. Immunol., 8, 717-724.
68. Merril, J.E., Kono, D.H., Clayton, J., Ando, D.G., Hinton, D.R. & Hofman, F.M. (1992), Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad Sci., USA, 89, 574-578.
69. Miller, A., Lider, O., Abramsky, O. & Weiner, H.L. (1994), Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur. J. Immunol., 24, 1026-1032.
70. Miller, A., Lider, O. & Weiner, H.L. (1991), Antigen-driven bystander suppression following oral administration of antigens. J. Exp. Med., 174, 791-798.
71. Miller, S. & Karpus, W. (1994), The immunopathogenesis and regualtion of T-cell mediated demyelinating diseases. Immunol. Today, 15, 356-361.
72. Montgomery, I.N. & Rauch, H.C. (1982), Experimental allergic encephalomyelitis (EAE) in mice: primary control of EAE susceptibility is outside the H-2 complex. J. Immunol., 128, 421-425.
73. Mosmann, T.R. (1994), Cytokine patterns during progression to AIDS. Science, 265, 193-194, 244-252.
74. Mosmann, T.R. & Coffman, R.L. (1989a), Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol., 46, 111-147.
75. Mosmann, T.R. & Coffman, R.L. (1989b), Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol., 7, 145-173.
76. Mosmann, T.R. & Sad, S. (1996), The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol. Today, 17, 138-146.
77. Mowat, A.M., Lamont, A.G., Strobel, S. & Mackenzie, S. (1987), The role of antigen processing and suppressor T cells in immune responses to dietary proteins in mice. Adv. Exp. Med. Biol., 216A, 709-720.
78. Nelson, P.A., Akselband, Y., Dearborn, S.M., Al-Sabbagh, A., Tian, Z.J., Gonnella, P.A., Zamvil, S.S., Chen, Y. & Weiner, H.L. (1996), Effect of oral beta interferon on subsequent immune responsiveness. Ann. N. Y. Acad. Sci., 778, 145-155.
79. Neurath, M.F., Fuss, I., Kelsall, B.L., Presky, D.H., Waegell, W. & Strober, W. (1996), Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med, 183, 2605-2616.
80. Nicholson, L., Greer, J., Sobel, R., Lees, M. & Kuchroo, V. (1995), An altered peptide ligand mediates immune deviation and prevents EAE. Immunity, 3, 397-405.
81. Nicholson, L.A., Murtaza, A., Hafler, B.P., Sette, A. & Kuchroo, V.K. (1997), A T cell antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis indcued with multiple myelin antigens. Proc. Natl. Acad. Sci., USA, 94, 9279-9284.
82. Nicholson, L.B., Waldner, H., Carrizosa, A.M., Sette, A., Collins, M. & Kuchroo, V.K. (1998), Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. Proc. Natl Acad. Sci., USA, 95, 264-269.
83. Nussenblatt, R.B., Caspi, R.R., Mahdi, R., Chan, C.C., Roberge, F., Lider, O. & Weiner, H.L. (1990), Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol., 144, 1689-1695.
84. Nussenblatt, R.B., Gery, I., Weiner, H.L., Ferris, F., Shiloach, J., Ramaley, N., Perry, C., Caspi, R., Hafler, D.A., Foster, S. & Whitcup, S.M. (1997), Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am. J. Opthal., 123, 583-592.
85. Panitch, H.S., Hirsch, R.L., Haley, A.S. & Johnson, K.P. (1987), Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet, 1, 893.
86. Paul, W. & Seder, R.A. (1994), Lymphocyte response and cytokines. Cell, 76, 241-251.
87. Pearson, C.I., van Ewijk, W. & McDevitt, H.O. (1997), Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive transgenic mice. J. Exp. Med., 185, 583-599.
88. Pettinelli, C. & McFarlin, D. (1981), Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Ly1+2-lymphocytes. J. Immunol, 127, 1420.
89. Powrie, F., Carlino, J., Leach, M.W., Mauze, S. & Coffman, R.L. (1996), A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB (low) CD4+ T cells. J. Exp. Med., 183, 2669-2674.
90. Prabhu Das, M., Nicholson, L.B., Greer, J.M. & Kuchroo, V.K. (1997), Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein. J. Exp. Med., 186, 867-876.
91. Racioppi, L., Ronchese, F., Matis, L.A. & Germain, R.N. (1993), Peptide major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-independent intracellular signalling. J. Exp. Med., 1993, 1047-1060.
92. Racke, M.K., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevach, E.M. & Röcken, M. (1994), Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med., 180, 1961-1966.
93. Rizzo, L.V., Miller-Rivero, N.E., Chan, C.-C., Wiggert, B., Nussenblatt, R.B. & Caspi, R.R. (1994), Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Invest., 94, 1668-1672.
94. Rollwagen, F.M. & Baqar, S. (1996), Oral cytokine administration. Immunol. Today, 17, 548-550.
95. Romagnani, S. (1994), Lymphokine production by human T cells in disease states. Annu. Rev. Immunol., 12, 227-257.
96. Rudick, R., Ransohoff, R. & Peppler, R. (1996), Interferon beta induces IL-10 expression: relevance to multiple sclerosis. Ann. Neurol., 40, 618-627.
97. Sakai, K., Zamvil, S.S., Mitchell, D.J., Hodgkinson, S., Rothbard, J.B. & Steinman, L. (1989), Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Proc. Nat. Acad. Sci., USA, 86, 9470-9474.
98. Salgame, P., Abrams, J.S., Clayberger, C., Goldstein, H., Convit, J., Modlin, R.L. & Bloom, B.R. (1991), Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science, 254, 279-254.
99. Samoilova, E.B., Horton, J.L., Zhang, H., Khoury, S.J., Weiner, H.L. & Chen, Y. (1998), CTLA4 is required for the induction of high dose oral tolerance. Int. Immunol., 10, 491-498.
100. Santos, L.M.B., Al-Sabbagh, A., Londono, A. & Weiner, H.L. (1994), Oral tolerance to myelin basic protein induces regulatory TGF-β-secreting T cells in Peyer's patches of SJL mice. Cell. Immunol., 157, 439-447.
101. Seder, R.A., Gazzinelli, R., Sher, A. & Paul, W.E. (1993), Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Nat. Acad. Sci., USA, 90, 10188-10192.
102. Seder, R.A., Marth, T., Sieve, M.C., Strober, W., Letterio, J.J., Roberts, A.B. & Kelsall, B. (1998), Factors involved in the differentiation of TGF-β-producing cells from naive CD4+ T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production. J. Immunol. (in press).
103. Seder, R.A. & Paul, W.E. (1994), Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol., 12, 635-673.
104. Segal, B.M. & Shevach, E.M. (1996), IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med., 184, 771-775.
105. Shaw, M.K., Lorens, J.B., Dhawan, A., DalCanto, R., Tse, H.Y., Tran, A.B., Bonpane, C., Eswaran, S.L., Brocke, S., Sarvetnick, N., Steinman, L., Nolan, G.P. & Fathman, C.G. (1997), Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med., 185, 1711-1714.
106. Shull, M.M., Ormsby, I., Kier, A.B., Pawlowski, S., Diebold, R.J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziata, N. & Doetschman, T. (1992), Targeted disruption of the mouse transforming growth factor-B1 gene results in multifocal inflammatory disease. Nature, 359, 693-699.
107. Sieper, J., Kary, S., Sörensen, H., Alten, R., Eggens, U., Hüge, W., Hiepe, F., Kühne, A., Listing, J., Ulbrich, N., Braun, J., Zink, A. & Mitchison, N.A. (1996), Oral type II collagen treatment in early rheumatoid arthritis. Arthritis Rheum., 39, 41-51.
108. Sloan-Lancaster, J. & Allen, P.M. (1996), Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol., 14, 1-27.
109. Sloan-Lancaster, J., Evavold, B.D. & Allen, P.M. (1993), Induction of T cell anergy by altered T cell receptor ligand on live antigen presenting cells. Nature, 363, 156-159.
110. Smilek, D.E., Wraith, D.C., Hodgkinson, S., Dwivedy, S., Steinman, L. & McDevitt, H.O. (1991), A single amino acid change in myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Nat. Acad. Sci., USA, 88, 9633-9637.
111. Smith, D., Balshov, K., Hafler, D., Khoury, S. & Weiner, H. (1997), Immune deviation following cyclophosphamide/ methylprednisolone treatment of multiple sclerosis: Increased IL-4 and associated eosinophilia. Ann. Neurol., 42, 313-318.
112. Street, N.E. & Mosmann, T.R. (1991), Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J, 5, 171-177.
113. Sun, J.-B., Holmgren, C. & Czerkinsky, C. (1994), Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci., USA, 91, 10795-10799.
114. Sun, J.B., Rask, C., Olsson, T., Holmgren, J. & Czerkinsky, C. (1996), Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci., USA, 93, 7196-7201.
115. Swain, S.L., Weinberg, A.D., English, M. & Huston, G. (1990), IL-4 directs the development of Th2-like helper effectors. J. Immunol., 145, 3796-3806.
116. Tada, Y., Ho, A., Koh, D.R. & Mak, T.W. (1996), Collagen-induced arthritis in CD4-or CD8-deficient mice. J. Immunol., 156, 4520-4526.
117. Takashima, H., Smith, D.R., Fukaura, H., Khoury, S.J., Hafler, D.A. & Weiner, H.L. (1998), Cyclophosphamide induces myelin antigen specific IL-4 secreting T cells in multiple sclerosis patients. AAN 1998 Scientific Abstract Program (in press).
118. Teuscher, C., Blankenhorn, E.P. & Hickey, W.F. (1987), Differential susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis among BALB/c substrains, Cell. Immunol., 110, 294-304.
119. Tisch, R., Yang, X.-D., Singer, S.M., Liblau, R.S., Fugger, L. & McDevitt, H.O. (1993), Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature, 366, 72-75.
120. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M.K. & Adorini, L. (1995), Interleukin 12 administration induces T helper type 1 cell and accelerates autoimmune diabetes in NOD mice. J. Exp. Med., 181, 817-821.
121. Trentham, D., Dynesius-Trentham, R., Orav, E., Combitchi, D., Lorenzo, C., Sewell, K., Hafler, D. & Weiner, H. (1993), Effects of oral administration of type II collagen on rheumatoid arthritis. Science, 261, 1727-1730.
122. H1 cells. Immunol. Today, 14, 335-338.
123. Tuohy, V.K., Sobel, R.A. & Lees, M.B. (1988), Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice. J. Immunol., 140, 1868-73.
124. Van Houten, N. & Blake, S.F. (1996), Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol., 157, 1337-1341.
125. Vandenbark, A., Chou, Y., Whitman, R., Mass, M., Buenafe, A., Liefeld, D., Kavanagh, D., Cooper, S., Hashim, G. & Offner, H. (1996), Treatment of MS with T cell receptor peptides: Results of a double-blind pilot trial. Nature Med., 2, 1109-1115.
126. Waldor, M.K., Sriram, S., Hardy, R., Herzenberg, L.A., Lanier, L., Lim, M. & Steinman, L. (1985), Reversal of experimental allergic encephalomyelitis with a monoclonal antibody to a T cell subset marker (L3T4). Science, 227, 415-417.
127. Wauben, M., Boog, C., Zee, R.V.D., Joosten, I., Schlief, A. & Eden, W.V. (1992), Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: More than blocking alone. J. Exp. Med., 176, 667.
128. Weiner, H.L. (1997), Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today, 18, 335-343.
129. Weiner, H.L., Mackin, G.A., Matsui, M., Orav, E.J., Khoury, S.J., Dawson, D.M. & Hafler, D.A. (1993), Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science, 259, 1321-1324.
130. Weiner, H.L. & Mayer, L.F. (1996), Oral tolerance: mechanisms and applications. Ann. N.Y. Acad. Sci., 778, 1-453.
131. Wells, H.G. (1911), Studies on the chemistry of anaphylaxis (III). Experiments with isolated proteins, especially those of the hen's egg. J. Infect. Dis., 8, 147-171.
132. Whitacre, C.C., Gienapp, I.E., Orosz, C.G. & Bitar, D. (1991), Oral tolerance in experimental autoimmune encephalomyelits. III. Evidence for clonal anergy. J. Immunol., 147, 2155-2163.
133. Wilson, A.D., Baily, M., Williams, N.A. & Stokes, C.R. (1991), The in vivo production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur. J. Immunol., 21, 2333-2339.
134. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M.N., Cuzner, M.L. & Hafler, D.A. (1995a), Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med., 182, 1985-1996.
135. Windhagen, A., Schloz, C., Hollsberg, P., Fukaura, H., Sette, A. & Hafler, D. (1995b), Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity, 2, 373-380.
136. Wraith, D.C., McDevitt, H.O., Steinman, L. & Acha-Orba, H. (1989a), T cell recognition as the target for immune intervention in autoimmune disease. Cell, 57, 709-715.
137. Wraith, D.C., Smilek, D.E., Mitchell, D.J., Steinman, L. & McDevitt, H.O. (1989b), Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell, 59, 247-255.
138. 2 cells in murine Peyer's patches by oral immunization. Int. Immunol., 4, 433-445.
139. Zamvil, S.S. & Steinman, L. (1990), The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol., 8, 579-621.
140. Zhang, J., Markovic, S., Raus, J., Lacet, B., Weiner, H.L. & Hafler, D.A. (1993), Increased frequency of IL-2 responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med., 179, 973-984.
141. Zhang, Z. & Michael, J.G. (1990), Orally inducible immune unresponsiveness is abrogated by IFN-γ treatment. J. Immunol., 144, 4163-4165.